The sleep inducing brain lipid cis-oleamide (cOA) does not modulate serotonergic transmission in the CA1 pyramidal neurons of the hippocampus in vitro

Neuropharmacology

Volumn 46, Issue 1, 2004, Pages 63-73

  Dougalis, Antonios ^a   Lees, George ^a   Ganellin, C Robin ^b  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

5 HT 1A and 5 HT2 receptors; cis 9,10 Octadeceneoamide; cis Oleamide; Hippocampus; Serotonin; Sleep

Indexed keywords

AZASETRON; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; OLEAMIDE; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 2 RECEPTOR; SEROTONIN 3 RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; EVOKED RESPONSE; HIPPOCAMPUS; HYPERPOLARIZATION; IN VITRO STUDY; INHIBITORY POSTSYNAPTIC POTENTIAL; LOW DRUG DOSE; MALE; MEMBRANE STEADY POTENTIAL; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; PYRAMIDAL NERVE CELL CA1; RAT;

EID: 0344256516     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(03)00297-1     Document Type: Article

References (53)

1. Anderson W.W., Collingridge G.L. The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events. J. Neurosci. Methods. 108:2001;71-83.
2. Andrade R., Chaput Y. 5-Hydroxytryptamine 4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus. J. Pharmacol. Exp. Ther. 257:1991;930-937.
3. Andrade R., Nicoll R.A. Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro. J. Physiol. 394:1987;99-124.
4. Basile A.S., Hanus L., Mendelson W.B. Characterization of the hypnotic properties of oleamide. Neuroreport. 10:1999;947-951.
5. Beck S.G. 5-Carboxyamidotryptamine mimics only the 5-HT elicited hyperpolarization of hippocampal pyramidal cells via 5-HT1A receptor. Neurosci. Lett. 99:1989;101-106.
6. Bennett J.P. Jr., Snyder S.H. Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors. Mol. Pharmacol. 12:1976;373-389.
7. Blanton M.G., Lo Turco J.J., Kriegstein A.R. Whole cell recording from neurons in slices of reptilian and mammalian cerebral cortex. J. Neurosci. Methods. 30:1989;203-210.
8. Blaschke M., Gremmels D., Everts I., Weigand E., Heinemann S.F., Hollmann M., Keller B.U. Pharmacological differentiation between neuronal and recombinant glutamate receptor channels expressed in Xenopus oocytes. Neuropharmacology. 36:1997;1489-1501.
9. Boger D.L., Henriksen S.J., Cravatt B.F. Oleamide: an endogenous sleep-inducing lipid and prototypical member of a new class of biological signaling molecules. Curr. Pharm. Des. 4:1998a;303-314.
10. Boger D.L., Patterson J.E., Jin Q. Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide. Proc. Natl. Acad. Sci. USA. 95:1998b;4102-4107.
11. Carley D.W., Paviovic S., Janelidze M., Radulovacki M. Functional role for cannabinoids in respiratory stability during sleep. Sleep. 25:2002;391-398.
12. Cheer J.F., Cadogan A.K., Marsden C.A., Fone K.C., Kendall D.A. Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors. Neuropharmacology. 38:1999;533-541.
13. Corradetti R., Ballerini L., Pugliese A.M., Pepeu G. Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices. Neuroscience. 46:1992;511-518.
14. Coyne L., Lees G., Nicholson R.A., Zheng J., Neufield K.D. The sleep hormone oleamide modulates inhibitory ionotropic receptors in mammalian CNS in vitro. Br. J. Pharmacol. 135:2002;1977-1987.
15. Cravatt B.F., Prospero-Garcia O., Siuzdak G., Gilula N.B., Henriksen S.J., Boger D.L., Lerner R.A. Chemical characterization of a family of brain lipids that induce sleep. Science. 268:1995;1506-1509.
16. Dugovic C. Functional activity of 5-HT2 receptors in the modulation of the sleep/wakefulness states. J. Sleep Res. 1:1992;163-168.
17. Dugovic C. Role of serotonin in sleep mechanisms. Rev. Neurol. (Paris). 157:2001;S16-S19.
18. Dugovic C., Wauquier A., Leysen J.E., Marrannes R., Janssen P.A. Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat. Psychopharmacology (Berl). 97:1989;436-442.
19. Dzoljic M.R., Ukponmwan O.E., Saxena P.R. 5-HT1-like receptor agonists enhance wakefulness. Neuropharmacology. 31:1992;623-633.
20. Fedorova I., Hashimoto A., Fecik R.A., Hedrick M.P., Hanus L.O., Boger D.L., Rice K.C., Basile A.S. Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems. J. Pharmacol. Exp. Ther. 299:2001;332-342.
21. Gulyas A.I., Acsady L., Freund T.F. Structural basis of the cholinergic and serotonergic modulation of GABAergic neurons in the hippocampus. Neurochem. Int. 34:1999;359-372.
22. Gustafson E.L., Durkin M.M., Bard J.A., Zgombick J., Branchek T.A. A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-HT7 receptor in rat brain. Br. J. Pharmacol. 117:1996;657-666.
23. Hanus L.O., Fales H.M., Spande T.F., Basile A.S. A gas chromatographic-mass spectral assay for the quantitative determination of oleamide in biological fluids. Anal. Biochem. 270:1999;159-166.
24. Hedlund P.B., Danielson P.E., Thomas E.A., Slanina K., Carson M.J., Sutcliffe J.G. No hypothermic response to serotonin in 5-HT7 receptor knockout mice. Proc. Natl. Acad. Sci. USA. 100:2003;1375-1380.
25. Huidobro-Toro J.P., Harris R.A. Brain lipids that induce sleep are novel modulators of 5-hydroxytryptamine receptors. Proc. Natl. Acad. Sci. USA. 93:1996;8078-8082.
26. Huitron-Resendiz S., Gombart L., Cravatt B.F., Henriksen S.J. Effect of oleamide on sleep and its relationship to blood pressure, body temperature, and locomotor activity in rats. Exp. Neurol. 172:2001;235-243.
27. Kantor S., Jakus R., Bodizs R., Halasz P., Bagdy G. Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift. Brain Res. 943:2002;105-111.
28. Lee K., Dixon A.K., Pinnock R.D. Serotonin depolarizes hippocampal interneurones in the rat stratum oriens by interaction with 5HT2 receptors. Neurosci. Lett. 270:1999;56-58.
29. Lees G., Dougalis A. cis-Oleamide does not modulate serotonergic transmission in CA1 pyramidal cells of the rat hippocampal slice. J. Physiol. (London). 544:2002;70P.
30. Lees G., Edwards M.D., Hassoni A.A., Ganellin C.R., Galanakis D. Modulation of GABA(A) receptors and inhibitory synaptic currents by the endogenous CNS sleep regulator cis-9,10-octadecenoamide (cOA). Br. J. Pharmacol. 124:1998;873-882.
31. Leonard B.E. Serotonin receptors and their function in sleep, anxiety disorders and depression. Psychother. Psychosom. 65:1996;66-75.
32. Lovenberg T.W., Erlander M.G., Baron B.M., Sutcliffe J.G. Cloning of new 5-HT receptors. Int. Clin. Psychopharmacol. 8:(Suppl. 2):1993;19-23.
33. Mechoulam R., Fride E., Hanus L., Sheskin T., Bisogno T., Di M.V., Bayewitch M., Vogel Z. Anandamide may mediate sleep induction. Nature. 389:1997;25-26.
34. Mendelson W.B., Basile A.S. The hypnotic actions of the fatty acid amide, oleamide. Neuropsychopharmacology. 25:2001;S36-S39.
35. Moore R.Y., Halaris A.E. Hippocampal innervation by serotonin neurons of the midbrain raphe in the rat. J. Comp. Neurol. 164:1975;171-183.
36. Pompeiano M., Palacios J.M., Mengod G. Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res. Mol. Brain Res. 23:1994;163-178.
37. Pugliese A.M., Passani M.B., Corradetti R. Effect of the selective 5-HT1A receptor antagonist WAY 100635 on the inhibition of e.p.s.ps produced by 5-HT in the CA1 region of rat hippocampal slices. Br. J. Pharmacol. 124:1998;93-100.
38. Ropert N., Guy N. Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro. J. Physiol. 441:1991;121-136.
39. Salgado-Commissariat D., Alkadhi K.A. Serotonin inhibits epileptiform discharge by activation of 5-HT1A receptors in CA1 pyramidal neurons. Neuropharmacology. 36:1997;1705-1712.
40. Segal M. The action of serotonin in the rat hippocampal slice preparation. J. Physiol. 303:1980;423-439.
41. Sharpley A.L., Cowen P.J. Effect of pharmacologic treatments on the sleep of depressed patients. Biol. Psychiatry. 37:1995;85-98.
42. Sharpley A.L., Solomon R.A., Fernando A.I., Roza Davis J.M., Cowen P.J. Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans. Psychopharmacology (Berl). 101:1990;568-569.
43. Sharpley A.L., Elliott J.M., Attenburrow M.J., Cowen P.J. Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors. Neuropharmacology. 33:1994;467-471.
44. Shen R.Y., Andrade R. 5-Hydroxytryptamine2 receptor facilitates GABAergic neurotransmission in rat hippocampus. J. Pharmacol. Exp. Ther. 285:1998;805-812.
45. Smith M.I., Piper D.C., Duxon M.S., Upton N. Effect of SB-243213, a selective 5-HT(2C) receptor antagonist, on the rat sleep profile: a comparison to paroxetine. Pharmacol. Biochem. Behav. 71:2002;599-605.
46. Staubli U., Xu F.B. Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory and LTP induction in the freely moving rat. J. Neurosci. 15:1995;2445-2452.
47. Thomas E.A., Carson M.J., Neal M.J., Sutcliffe J.G. Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide. Proc. Natl. Acad. Sci. USA. 94:1997;14115-14119.
48. Thomas E.A., Carson M.J., Sutcliffe J.G. Oleamide-induced modulation of 5-hydroxytryptamine receptor-mediated signaling. Ann. N. Y. Acad. Sci. 861:1998;183-189.
49. Thomas E.A., Cravatt B.F., Sutcliffe J.G. The endogenous lipid oleamide activates serotonin 5-HT7 neurons in mouse thalamus and hypothalamus. J. Neurochem. 72:1999;2370-2378.
50. Tissier M.H., Lainey E., Fattaccini C.M., Hamon M., Adrien J. Effects of ipsapirone, a 5-HT1A agonist, on sleep/wakefulness cycles: probable post-synaptic action. J. Sleep Res. 2:1993;103-109.
51. Wauquier A., Dugovic C. Serotonin and sleep-wakefulness. Ann. NY Acad. Sci. 600:1990;447-458.
52. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature. 410:2001;588-592.
53. Woodruff G.N., Hall M.D., Reynolds T., Pinnock R.D. Bombesin receptors in the brain. Ann. NY Acad. Sci. 780:1996;223-243.